Literature DB >> 7592863

Interaction of [fluorescein-Trp25]glucagon with the human glucagon receptor expressed in Drosophila Schneider 2 cells.

M R Tota1, L Xu, A Sirotina, C D Strader, M P Graziano.   

Abstract

The human glucagon receptor was expressed at high density in Drosophila Schneider 2 (S2) cells. Following selection with G418 and induction with CuSO4, the cells expressed the receptor at a level of 250 pmol/mg of membrane protein. The glucagon receptor was functionally coupled to increases in cyclic AMP in S2 cells. Protein immunoblotting with anti-peptide antibodies revealed the expressed receptor to have an apparent molecular mass of 48 kDa, consistent with low levels of glycosylation in this insect cell system. Binding of [fluorescein-Trp25]glucagon to S2 cells expressing the glucagon receptor was monitored as an increase in fluorescence anisotropy along with an increase in fluorescence intensity. Anisotropy data suggest that the mobility of the fluorescein is restricted when the ligand is bound to the receptor. Kinetic analysis indicates that the binding of glucagon to its receptor proceeds via a bimolecular interaction, with a forward rate constant that is several orders of magnitude slower than diffusion-controlled. These data would be consistent with a conformational change upon the binding of agonist to the receptor. The combination of [fluorescein-Trp25]glucagon with the S2 cell expression system should be useful for analyzing glucagon receptor structure and function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592863     DOI: 10.1074/jbc.270.44.26466

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  A baculovirus superinfection system: efficient vehicle for gene transfer into Drosophila S2 cells.

Authors:  D F Lee; C C Chen; T A Hsu; J L Juang
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Using EGFP fusions to monitor the functional expression of GPCRs in the Drosophila Schneider 2 cells.

Authors:  Karl Brillet; Bénédicte G Perret; Valérie Klein; Franc Pattus; Renaud Wagner
Journal:  Cytotechnology       Date:  2008-01-19       Impact factor: 2.058

3.  Data quality in drug discovery: the role of analytical performance in ligand binding assays.

Authors:  Hermann Wätzig; Imke Oltmann-Norden; Franziska Steinicke; Hassan A Alhazmi; Markus Nachbar; Deia Abd El-Hady; Hassan M Albishri; Knut Baumann; Thomas Exner; Frank M Böckler; Sami El Deeb
Journal:  J Comput Aided Mol Des       Date:  2015-06-13       Impact factor: 3.686

4.  Generation of mice expressing the human glucagon receptor with a direct replacement vector.

Authors:  L L Shiao; M A Cascieri; M Trumbauer; H Chen; K A Sullivan
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

Review 5.  Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

Authors:  Rajashri Sridharan; Jeffrey Zuber; Sara M Connelly; Elizabeth Mathew; Mark E Dumont
Journal:  Biochim Biophys Acta       Date:  2013-09-18

6.  Site-specific biotinylation of human myeloid differentiation protein 88 in Drosophila melanogaster Schneider 2 cell cytoplasm.

Authors:  G Basile; M Peticca; S Catello
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

7.  Growth of recombinant Drosophila melanogaster Schneider 2 cells producing rabies virus glycoprotein in bioreactor employing serum-free medium.

Authors:  Adriana L L Galesi; Marcelo A Aguiar; Renato M Astray; Elisabeth F P Augusto; Angela M Moraes
Journal:  Cytotechnology       Date:  2008-03-02       Impact factor: 2.058

8.  Kinetic response of a Drosophila melanogaster cell line to different medium formulations and culture conditions.

Authors:  R Bovo; A L L Galesi; S A C Jorge; R A M Piccoli; A M Moraes; C A Pereira; E F P Augusto
Journal:  Cytotechnology       Date:  2008-04-17       Impact factor: 2.058

Review 9.  Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding.

Authors:  Leigh A Stoddart; Carl W White; Kim Nguyen; Stephen J Hill; Kevin D G Pfleger
Journal:  Br J Pharmacol       Date:  2015-11-05       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.